Tomoyuki Taguchi

Tomoyuki Taguchi is an experienced professional in the pharmaceutical and biotech industries, currently serving as the Integrated Evidence Generation Manager at Bayer since May 2022. In this role, responsibilities include evidence generation planning and execution for oncology, radiology, and ophthalmology, along with expanding real-world data knowledge in medical affairs. Prior experience includes a managerial position at BioMarin Pharmaceutical Inc., focusing on post-marketing medical evidence generation and clinical study management. At AstraZeneca, contributions involved evidence delivery for pre- and post-launched products through gap analysis and observational trial execution. A long tenure at Sanofi allowed for extensive work in oncology and hematology medical activities, including budget management, scientific publication management, and KOL communication. Tomoyuki Taguchi holds a Master of Pharmacy degree from Tokyo University of Pharmacy and Life Sciences.